BioMedix(TM) President & CEO John Romans Earns Honorary Doctorate of Humane Letters
President & CEO John Romans was awarded an Honorary Doctorate of Humane Letters by the New York College of Podiatric Medicine on October 20th, 2010.
- (1888PressRelease) November 03, 2010 - Saint Paul, MN - BioMedix™ announced today that President & CEO John Romans has been awarded an Honorary Doctorate of Humane Letters by the New York College of Podiatric Medicine. On October 20th, 2010, the New York College of Podiatric Medicine honored three distinguished individuals at its centennial year celebration, a convocation and testimonial luncheon held at the New York Academy of Medicine.
Criteria for recipients of this honor include qualities such as leadership and achievement in the healthcare field or in business; longstanding dedication to Podiatry and its allied disciplines; outstanding and exemplary character; and notable public service to the Tri-State region, the nation and the international community, whether it be through impressive professional accomplishments, elected office or leadership efforts as a volunteer.
"This award reflects a body of work achieved by a team of players and collaborators rather than that of an individual," stated Mr. Romans, "It has been a privilege to support and work with those who save countless lives across the country. I am proud of what BioMedix™ has accomplished and I am humbled by this acknowledgement from the New York College of Podiatric Medicine."
Mr. Romans, hooded by Thomas J. Fogerty, MD (inventor of the balloon embolectomy catheter), was recognized for both his individual contributions and for contributions made by BioMedix™ to the Podiatric community, including remarkable achievements in providing solutions that prolong and enhance life through the early detection of vascular disease. These solutions include the award-winning PADnet™+ device, which has completed over 320,000 patient tests to date, and TRAKnet™ DPM, the first and only Podiatry-specific Practice Management and EHR software to receive the prestigious American Podiatric Medical Association Seal of Acceptance. John Romans continues to focus BioMedix™ on providing the best tools to the Podiatric community.
About the New York College of Podiatric Medicine (NYCPM)
The New York College of Podiatric Medicine is a four-year medical school that has been a part of the fabric of the Harlem community since 1911. It offers comprehensive patient care to the residents of Harlem and neighboring communities. In its role as teaching institution, it is the premier source of new doctors of podiatric medicine who will provide quality podiatric medical care to underserved communities around the city, state, and country as well as to the nation's burgeoning older and elderly population. The College's clinical affiliate, the Foot Center of New York, sees nearly 25,000 patient visits each year, making it the largest such institution in the world.
BioMedix™ provides the only integrated suite of hardware, software and online services designed to cost-effectively detect Peripheral Arterial Disease (P.A.D.) and Chronic Venous Insufficiency (CVI). Vascular specialists, primary care providers, hospitals and health systems use our products to identify these patients. Our devices and Health Information Technology (HIT) software reduce mistakes, provide data for sound analysis, build practice revenue and streamline reimbursement while providing a platform that supports the continuum of care and increased quality outcomes. For more information about BioMedix™ products, call 877-854-0014 or log on to www.BioMedix.com.
PADnet™ and TRAKnet™ are trademarks of BioMedix™.